Literature DB >> 9556421

Causes of death in autopsied liver transplantation patients.

M Torbenson1, J Wang, L Nichols, A Jain, J Fung, M A Nalesnik.   

Abstract

Liver transplantation is an established treatment for multiple end-stage liver diseases, yet little information is available on the autopsy-determined causes of death in liver transplant recipients. We undertook a retrospective study of the immediate causes of death in all liver transplant recipients who underwent autopsy at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, from January 1982 to January 1997. Infections were the most frequent cause of death, present in 64% of a total of 321 cases. Overall, the infections were bacterial in 48% of the cases, fungal in 22%, and viral in 12%. The ratio of infectious to noninfectious causes of death did not change significantly during the 15-year study period, and the relative percentages of bacterial, fungal, and viral infections showed relatively little variation on a year-to-year basis. Two-thirds of all infections occurred during the first 100 days post transplantation. A precipitous drop in the number of infections (and the number of deaths) occurred by Day 90. Other major causes of death included liver failure (12%), pulmonary failure (10%), multiple organ system (8%), and cardiovascular causes (6%). Infections were the most frequent cause of death in this study population, suggesting that improvement in the prevention and treatment of infections is an important way to improve survival of liver transplant recipients.

Entities:  

Mesh:

Year:  1998        PMID: 9556421

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

1.  Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation.

Authors:  Alexander B Benson; James R Burton; Gregory L Austin; Scott W Biggins; Michael A Zimmerman; Igal Kam; Susan Mandell; Christopher C Silliman; Hugo Rosen; Marc Moss
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

Review 2.  Update and actual trends on bacterial infections following liver transplantation.

Authors:  Jose Luis del Pozo
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

3.  Perioperative bacterial infections in deceased donor and living donor liver transplant recipients.

Authors:  Joy Varghese; Narasimhan Gomathy; Perumalla Rajashekhar; Kota Venugopal; Arikichenin Olithselvan; Shanmugam Vivekanandan; Shanmugam Naresh; Chandrasekaran Sujatha; Srinivasan Vijaya; Venkataraman Jayanthi; Mohamed Rela
Journal:  J Clin Exp Hepatol       Date:  2012-04-12

4.  Infections after living donor liver transplantation in children.

Authors:  Jeong Eun Kim; Seak Hee Oh; Kyung Mo Kim; Bo Hwa Choi; Dae Yeon Kim; Hyung Rae Cho; Yeoun Joo Lee; Kang Won Rhee; Seong Jong Park; Young Joo Lee; Sung Gyu Lee
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

Review 5.  Overview of the indications and contraindications for liver transplantation.

Authors:  Stefan Farkas; Christina Hackl; Hans Jürgen Schlitt
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

6.  Infections developing in patients undergoing liver transplantation: Recipients of living donors may be more prone to bacterial/fungal infections.

Authors:  Tansu Yamazhan; Cansu Bulut Avşar; Murat Zeytunlu; Meltem Taşbakan; Rüçhan Sertöz; Ayşın Zeytinoğlu; Şöhret Aydemir; Ömer Ünalp; Orkan Ergün; Alper Uğuz; Funda Özgenç; Fulya Günşar; İlker Turan; Sezgin Ulukaya; Nuri Deniz; Funda Yilmaz; Deniz Nart; Ezgi Güler; Kutsal Turhan; Zeki Karasu
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

7.  SPECT myocardial perfusion imaging in liver transplantation candidates.

Authors:  W Lane Duvall; Aditi Singhvi; Nidhi Tripathi; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2018-08-23       Impact factor: 5.952

8.  Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study.

Authors:  Andreas A Schnitzbauer; Marcus N Scherer; Justine Rochon; Johannes Sothmann; Stefan A Farkas; Martin Loss; Edward K Geissler; Aiman Obed; Hans J Schlitt
Journal:  BMC Nephrol       Date:  2010-09-14       Impact factor: 2.388

9.  Management and Outcome of Liver Abscesses After Liver Transplantation.

Authors:  Iago Justo; Carlos Jiménez-Romero; Alejandro Manrique; Oscar Caso; Jorge Calvo; Felix Cambra; Alberto Marcacuzco
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

10.  Evaluation of cytomegalovirus infection after six months of liver transplantation in children in shiraz, southern iran.

Authors:  N Honar; M H Imanieh; S M Dehghani; M Haghighat; B Geramizadeh; R Yaghobi; A Alborzi; M Ziaeian; K Kazemi; S Nikeghbalian; A Bahador; H Salahi; S A Malek Hosseini
Journal:  Int J Organ Transplant Med       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.